Results of Annual General Meeting
09 May 2019
Convatec Group Plc (“Convatec”), a leading global medical products and technologies company, held its annual general meeting today.
Download Full Press Release
PDF
Enquiries
|
|
investorrelations@convatec.com |
|
John Crosse, VP Investor Relations |
+44 (0)7500 141435 |
|
Mark Reynolds, Director Investor Relations |
+44 (0)7551 036625 |
|
|
|
|
Bobby Leach, VP Group Corporate Affairs |
+44 (0)7770 842226 |
|
Finsbury |
+44 (0)207 2513801 |
Press Release
01-Aug-22
Corporate
Financial Performance
Convatec Group Plc First Half Results 2019
Convatec Group Plc First Half Results 2019
Read more Read more17-Jul-22
Infusion Care
Beta Bionics and Convatec announce partnership to bring Unomedical infusion s...
Beta Bionics and Convatec announce partnership to bring Unomedical infusion set portfolio to the iLet™ Bionic Pancrea...
Read more Read more30-Oct-19
Corporate
Financial Performance
Trading Update for the three months ended 30 September 2019
Trading Update for the three months ended 30 September 2019
Read more Read more18-Sep-19
Continence Care
Acquisition of Southlake Medical Supplies
Acquisition of Southlake Medical Supplies
Read more Read more19-Aug-19
Corporate
Our People
John McAdam appointed Chairman of Convatec
John McAdam appointed Chairman of Convatec
Read more Read more07-Jun-19
Advanced Wound Care
Convatec partners with EWMA to support Research Grants in 2019
Convatec partners with EWMA to support Research Grants in 2019
Read more Read more09-May-19
Corporate
Financial Performance
Results of Annual General Meeting
Results of Annual General Meeting
Read more Read more25-Mar-19
Corporate
Our People
Appointment of Chief Executive Officer
Appointment of Chief Executive Officer
Read more Read more